Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.
about
Characterization of E3Histone, a novel testis ubiquitin protein ligase which ubiquitinates histones.Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptorsPhosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53A novel hPirh2 splicing variant without ubiquitin protein ligase activity interacts with p53 and is down-regulated in hepatocellular carcinomaIdentification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domainsHuman PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancerThe ORF3 protein of porcine circovirus type 2 interacts with porcine ubiquitin E3 ligase Pirh2 and facilitates p53 expression in viral infectionAn androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP)Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription.Mice lacking the UBC4-testis gene have a delay in postnatal testis development but normal spermatogenesis and fertility.Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome.ART-27, an androgen receptor coactivator regulated in prostate development and cancer.The MDM2 gene family.Pathogenic polyglutamine expansion length correlates with polarity of the flanking sequences.Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.Molecular Analysis of the HOXA2-Dependent Degradation of RCHY1.Degradation and beyond: control of androgen receptor activity by the proteasome system.The role of ubiquitin-protein ligases in neurodegenerative disease.Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.Pirh2: an E3 ligase with central roles in the regulation of cell cycle, DNA damage response, and differentiationE3 ubiquitin ligase Pirh2 enhances tumorigenic properties of human non-small cell lung carcinoma cells.A novel oncoprotein Pirh2: rising from the shadow of MDM2.Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.The homeodomain transcription factor Hoxa2 interacts with and promotes the proteasomal degradation of the E3 ubiquitin protein ligase RCHY1.Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression.Proteasomal degradation unleashes the pro-death activity of androgen receptor.Axin determines cell fate by controlling the p53 activation threshold after DNA damage.High expression of Pirh2, an E3 ligase for p27, is associated with low expression of p27 and poor prognosis in head and neck cancers.Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo.Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoproteinProteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.SCY1-like 1 binding protein 1 (SCYL1-bp1) interacts with p53-induced RING H2 protein (Pirh2) after traumatic brain injury in rats.High Expression of Pirh2 is Associated with Poor Prognosis in Glioma.Dynamic rewiring of the androgen receptor protein interaction network correlates with prostate cancer clinical outcomes.
P2860
Q24298059-86456F4C-8A31-4E6E-A7CD-97AC270593D0Q24308715-AE6EF80E-2E17-487D-B6C0-9AF799F7A665Q24310675-85C77982-4E4D-4A10-9EAC-0B3B5EE10FBDQ24310839-0EE4F6B3-FDB2-4A33-8458-D9A90A3E3DFEQ24315623-09D70663-EC2F-4798-ACA2-996341C01F31Q24670460-7F088A7D-00D2-4441-9A1D-71CE44AEE6FEQ24676133-F2B40237-BCF8-4B67-AB2F-9CCB7483D2BBQ28258333-FCB7D6CF-FC6C-476B-AB66-AE5253722FF1Q28910351-B660D80A-2A80-47FE-A393-7AD2CB1AE7B2Q33925199-3B729012-37C2-4E95-8176-AE677CC801AAQ34287238-3209D79C-9482-478D-A4CF-FB82AA1DA0D3Q34288622-738CB6B0-2AC2-489D-B525-7BE07DBC25C2Q34460686-A6B0D17E-F441-40F2-9A40-E1CA4B7864E5Q34544146-2BB9B1FF-0A0F-4B54-85FD-C6DD74219910Q35688891-2EC2B45D-A8F1-45BA-B8E3-297C1336ECA6Q35819036-39AE140B-2CEE-49CB-A25F-1C92FF335553Q36539137-0E37DD19-0A1A-4EDB-975B-B2BEAA7DDC5EQ36565602-50685394-FF20-4A39-8856-110A9A4EDDA9Q36817627-622D2A77-CB7D-4115-B051-499A512D4E7DQ37505495-735EC560-D4FA-492D-B0F7-644BA19DB7D1Q37635616-B200CE55-DFF9-4AE6-8F38-E3C9F94EB21BQ37834073-BDDFD642-E512-45A2-8ABC-93F7754DACFCQ38016718-2F5606F7-FFF6-47BF-AB48-771BADA68C2AQ39061962-E726E6F6-0C1E-4A92-96B7-7EAF19C0A222Q39243442-6F58F415-BB9B-44B4-BF34-B31D8BF26365Q39702932-CDC9E08F-8544-4DC4-AAF4-8127ED835E20Q39803554-2D4BF783-BFA6-4DA4-BFB8-75754566ABBEQ39850997-B433454E-F8DA-489E-B759-A03F0DA1F13AQ40297593-8DBF40EC-BDED-4626-9B42-34EF50D9E1E4Q40378033-EA8BF16A-FE96-4F59-A16E-B3F852DB6D51Q42133297-483F76A6-60CE-46F9-9758-D74FDB1DD61AQ48131260-9E27639A-4C80-4883-9203-252436C4799AQ48281981-3401B7B1-7C46-4BD9-B587-481016DAB0FDQ53282043-BA587E0A-EE48-487C-A41A-A7E400FF3886
P2860
Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cloning and characterization o ...... uitin-protein ligase activity.
@ast
Cloning and characterization o ...... uitin-protein ligase activity.
@en
type
label
Cloning and characterization o ...... uitin-protein ligase activity.
@ast
Cloning and characterization o ...... uitin-protein ligase activity.
@en
prefLabel
Cloning and characterization o ...... uitin-protein ligase activity.
@ast
Cloning and characterization o ...... uitin-protein ligase activity.
@en
P2093
P356
P1476
Cloning and characterization o ...... quitin-protein ligase activity
@en
P2093
B Gottlieb
M A Trifiro
R Lumbroso
V Panet-Raymond
Y A Elhaji
P356
10.1677/JME.0.0290041
P577
2002-08-01T00:00:00Z